The Benefits and Risks of Oral Antiplatelet Therapy in Patients With Acute Coronary Syndrome
The Cardiovascular Insights for Primary Care Physicians eNewsletter Series summarizes key information and data on common cardiovascular issues facing primary care physicians today.
The third eNewsletter, The Benefits and Risks of Oral Antiplatelet Therapy in Patients with Acute Coronary Syndrome, reviews the evidence on the benefits and risks of oral antiplatelet therapies, with a focus on balancing ischemic and bleeding risk to optimize patient outcomes.
Funding for this newsletter series was provided by AstraZeneca
Sponsor
Funding for this newsletter series was provided by AstraZeneca
The Cardiovascular Insights for Primary Care Physicians eNewsletter Series summarizes key information and data on common cardiovascular issues facing primary care physicians today.
The third eNewsletter, The Benefits and Risks of Oral Antiplatelet Therapy in Patients with Acute Coronary Syndrome, reviews the evidence on the benefits and risks of oral antiplatelet therapies, with a focus on balancing ischemic and bleeding risk to optimize patient outcomes.
The Cardiovascular Insights for Primary Care Physicians eNewsletter Series summarizes key information and data on common cardiovascular issues facing primary care physicians today.
The third eNewsletter, The Benefits and Risks of Oral Antiplatelet Therapy in Patients with Acute Coronary Syndrome, reviews the evidence on the benefits and risks of oral antiplatelet therapies, with a focus on balancing ischemic and bleeding risk to optimize patient outcomes.
